Provided by Tiger Trade Technology Pte. Ltd.

Werewolf Therapeutics, Inc.

0.8150
+0.02903.69%
Volume:96.92K
Turnover:77.78K
Market Cap:39.56M
PE:-0.50
High:0.8150
Open:0.7900
Low:0.7869
Close:0.7860
52wk High:2.38
52wk Low:0.5301
Shares:48.54M
Float Shares:35.00M
Volume Ratio:0.60
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6177
EPS(LYR):-1.6273
ROE:-122.43%
ROA:-40.75%
PB:1.34
PE(LYR):-0.50

Loading ...

Company Profile

Company Name:
Werewolf Therapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
39
Office Location:
200 Talcott Ave,2nd Floor,Watertown,Massachusetts,United States
Zip Code:
02472
Fax:
- -
Introduction:
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule that is in Phase I clinical trial for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule, which is in Phase I clinical trial for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; and WTX-712, an IL-21 INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.

Directors

Name
Position
Daniel J. Hicklin
Chief Executive Officer, President and Director
Luke Evnin
Chairman
Alon Lazarus
Director
Anil Singhal
Director
Briggs Morrison
Director
Meeta Chatterjee
Director
Michael B. Atkins
Director
Michael Sherman
Director

Shareholders

Name
Position
Daniel J. Hicklin
Chief Executive Officer, President and Director
Michael Urban
Chief Financial Officer and Principal Accounting Officer
Chulani Karunatilake
Chief Technology Officer
Steven Bloom
Chief Business Officer